A number of research firms have changed their ratings and price targets for Synergy Pharmaceuticals (NASDAQ: SGYP): 10/26/2015 – Synergy Pharmaceuticals was downgraded by analysts at Vetr from a “strong-buy” rating to a “hold” rating. They now have a $5.92 price target on the stock. 10/15/2015 – Synergy Pharmaceuticals had its “buy” rating reaffirmed by […]
